AU2000230653A1 - Diagnosis and treatment of mental disorders - Google Patents
Diagnosis and treatment of mental disordersInfo
- Publication number
- AU2000230653A1 AU2000230653A1 AU2000230653A AU3065300A AU2000230653A1 AU 2000230653 A1 AU2000230653 A1 AU 2000230653A1 AU 2000230653 A AU2000230653 A AU 2000230653A AU 3065300 A AU3065300 A AU 3065300A AU 2000230653 A1 AU2000230653 A1 AU 2000230653A1
- Authority
- AU
- Australia
- Prior art keywords
- diagnosis
- treatment
- mental disorders
- mental
- disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000003745 diagnosis Methods 0.000 title 1
- 208000020016 psychiatric disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Psychiatry (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/GB2000/000159 WO2001052861A1 (en) | 2000-01-21 | 2000-01-21 | Diagnosis and treatment of mental disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2000230653A1 true AU2000230653A1 (en) | 2001-07-31 |
Family
ID=9883220
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2000230653A Abandoned AU2000230653A1 (en) | 2000-01-21 | 2000-01-21 | Diagnosis and treatment of mental disorders |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2000230653A1 (en) |
WO (1) | WO2001052861A1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5227371A (en) * | 1982-07-13 | 1993-07-13 | Eliezer Rapaport | Utilization of adenine nucleotides and/or adenosine and inorganic phosphate for elevation of liver, blood and blood plasma adenosine 5'-triphosphate concentrations |
JPS6429395A (en) * | 1987-07-24 | 1989-01-31 | Taisho Pharmaceutical Co Ltd | Adenosine compound |
US5677290A (en) * | 1990-05-10 | 1997-10-14 | Fukunaga; Atsuo F. | Therapeutic use of adenosine compounds as surgical anesthetics |
JP3943689B2 (en) * | 1998-01-09 | 2007-07-11 | 大塚製薬株式会社 | Diagnosis of schizophrenia |
-
2000
- 2000-01-21 AU AU2000230653A patent/AU2000230653A1/en not_active Abandoned
- 2000-01-21 WO PCT/GB2000/000159 patent/WO2001052861A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001052861A1 (en) | 2001-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002255248A1 (en) | Diagnosis, treatment and research of mental disorders | |
AU2002323258A1 (en) | Diagnosis and treatment of vascular disease | |
WO2002086502A8 (en) | Methods for the diagnosis and treatment of bone disorders | |
AU2003290548A1 (en) | Prevention and treatment of synucleinopathic disease | |
AU2001275177A1 (en) | Cardiac disease treatment and device | |
AU2001253565A1 (en) | Cardiac disease treatment and device | |
AU2001275176A1 (en) | Cardiac disease treatment and device | |
AU2002367535A1 (en) | Diagnosis and treatment of vascular disease | |
AU2001281369A1 (en) | Cardiac disease treatment and device | |
AU2001249835A1 (en) | Diagnosis and treatment of alzheimer's disease | |
WO2001078781A8 (en) | Methods for prevention and treatment of gastrointestinal disorders | |
AU2002225219A1 (en) | Diagnosis and treatment of multiple sclerosis | |
AU6910600A (en) | Methods for the treatment of mental disorders | |
AU2001256855A1 (en) | Preparation for the prevention and treatment of ocular disorders | |
AUPQ622600A0 (en) | Treatment and/or prevention of ocular pain | |
AU2002326813A1 (en) | Diagnosis and treatment of vascular disease | |
AU5908300A (en) | Prevention and treatment of amyloid-associated disorders | |
AU2001251306A1 (en) | Treatment of sleep disorders with hypocretin-1 | |
AU2002222108A1 (en) | Diagnosis and treatment of alzheimer's disease | |
AU7601400A (en) | Treatment and prevention of hepatic disorders | |
GB0128674D0 (en) | Treatment of sleep disorders and the like | |
AU2002341880A1 (en) | Diagnosis and treatment of vascular disease | |
AU7106300A (en) | Treatment of skin disorders | |
AU2002341604A1 (en) | Diagnosis and treatment of vascular disease | |
AU2432001A (en) | Treatment of mental conditions including depression |